Speciality
Professor of Medicine in the Division of Digestive and Liver Diseases at University of Texas Southwestern Medical Center, Chief of Hepatology and Medical Director of the Liver Tumor Program.

Personal Information

Dr. Signal has obtained NIH funding examining the hepatocellular carcinoma (HCC) care continuum, ranging from HCC prevention to screening and early detection to treatment and survivorship. He has over 200 peer-reviewed original publications and has been awarded the Willis C Maddrey Distinguished Chair in Liver Disease, Dedman Family Scholar in Clinical Care, and Blue Faery Award for Excellence in Liver Cancer Research.